ArticleFrontiers in pharmacology2026

Amelioration of CKD-induced cardiomyocyte hypertrophy by pegmolesatide: involvement of JAK2/STAT3 inhibition and mitochondrial protection.

Xinyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.